Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients

被引：0
|
作者：
Nishio, Minako [1 ]
Kojitani, Yoshiki [1 ]
Kitashiro, Saya [1 ]
Ishiduka, Yasunobu [1 ]
Otsuka, Tomoyuki [1 ]
Nishida, Naohiro [1 ]
Fujisawa, Fumie [1 ]
Sugimoto, Naotoshi [1 ]
Yagi, Toshinari [1 ]
Souma, Ai [2 ]
Kanaoka, Haruka [2 ]
Oyamayama, Yuri [2 ]
Taniguchi, Azusa [2 ]
Nakajima, Satomi [2 ]
Seto, Yukiko [2 ]
Kusama, Hiroki [2 ]
Watanabe, Noriyuki [2 ]
Matsui, Saki [2 ]
Nakayama, Takahiro [2 ]
Kudou, Toshihiro [1 ]
机构：
[1] Osaka Int Canc Inst, Osaka Prefectural Hosp Org, Dept Med Oncol, Osaka, Japan
[2] Osaka Int Canc Inst, Osaka Prefectural Hosp Org, Dept Breast Surg, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.3098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P67-5
引用
收藏
页码：S1465 / S1465
页数：1
相关论文
共 50 条
  • [1] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Michel, Laura L.
    von Au, Alexandra
    Mavratzas, Athanasios
    Smetanay, Katharina
    Schuetz, Florian
    Schneeweiss, Andreas
    TARGETED ONCOLOGY, 2020, 15 (04) : 415 - 428
  • [2] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Laura L. Michel
    Alexandra von Au
    Athanasios Mavratzas
    Katharina Smetanay
    Florian Schütz
    Andreas Schneeweiss
    Targeted Oncology, 2020, 15 : 415 - 428
  • [3] Triple-negative breast cancer: Our experience
    Bertolini, Alessandro
    Menatti, Elisabetta
    Fusco, Ornella
    Berardi, Eliana
    Malugani, Fabio
    Fiumano, Mario
    ANNALS OF ONCOLOGY, 2007, 18 : 45 - 45
  • [4] The Evolving Role of Immune Checkpoint Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Steiner, Meghan
    Tan, Antoinette R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (05) : 305 - 315
  • [5] Window of opportunity trials with immune checkpoint inhibitors in triple-negative breast cancer
    Quintana, A.
    Saini, K. S.
    Vidal, L.
    Peg, V.
    Slebe, F.
    Loibl, S.
    Curigliano, G.
    Schmid, P.
    Cortes, J.
    ESMO OPEN, 2024, 9 (10)
  • [6] The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
    Singh, Sima
    Numan, Arshid
    Maddiboyina, Balaji
    Arora, Saahil
    Riadi, Yassine
    Md, Shadab
    Alhakamy, Nabil A.
    Kesharwani, Prashant
    DRUG DISCOVERY TODAY, 2021, 26 (07) : 1721 - 1727
  • [7] Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
    Said, Sawsan Sudqi
    Ibrahim, Wisam Nabeel
    BIOMEDICINES, 2024, 12 (02)
  • [8] Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer
    Scarpa, Joseph R.
    Montagna, Giacomo
    Plitas, George
    Gulati, Amitabh
    Fischer, Gregory W.
    Mincer, Joshua S.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study
    Valenza, Carmine
    Trapani, Dario
    Zagami, Paola
    Antonarelli, Gabriele
    Bielo, Luca Boscolo
    Nicolo, Eleonora
    Ribeiro, Joana Mourato
    Guidi, Lorenzo
    Reduzzi, Carolina
    Spotti, Martina
    Adamoli, Laura
    Cortes, Javier
    Pistilli, Barbara
    Tolaney, Sara M.
    Ueno, Naoto
    Layman, Rachel M.
    Cristofanilli, Massimo
    Carey, Lisa A.
    Munzone, Elisabetta
    Criscitiello, Carmen
    Lynce, Filipa
    Woodward, Wendy A.
    Curigliano, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2024, 213
  • [10] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhao, Weihong
    Zhang, Zheng
    Zhang, Yadi
    Chen, Yimeng
    Zhu, Yimin
    Liu, Chuanling
    Shao, Jiakang
    Zhang, Li
    Liu, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345